Access cutting-edge atopic dermatitis treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access atopic dermatitis specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atopic dermatitis treatment provided free
This is a Phase 1b, randomized, placebo/vehicle-controlled, double-blinded, multi-center trial. It is designed to assess the safety and efficacy of S. hominis A9 (ShA9) topical application as a treatment for atopic dermatitis (AD). The trial will enroll adults and adolescents with atopic dermatitis who are culture positive for S. aureus colonization. The primary safety objective of this study is to compare the safety profile of ShA9 to placebo (vehicle) over 14 weeks of application, which inclu
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Check if you qualify for this atopic dermatitis clinical trial in Chicago, IL
If you're searching for atopic dermatitis treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atopic dermatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.